Comdisco sells Medical Exchange assets

Article

Asset management and equipment refurbishing firm Comdisco has sold certain assets of its medical equipment refurbishing and mobile diagnostic business, Comdisco Medical Exchange, to a private investment group. The group includes former Comdisco

Asset management and equipment refurbishing firm Comdisco has sold certain assets of its medical equipment refurbishing and mobile diagnostic business, Comdisco Medical Exchange, to a private investment group. The group includes former Comdisco Healthcare Group president Chip Halverson and other Comdisco Healthcare executives in addition to New York City-based healthcare investment company Galen Partners.

Comdisco made the move as part of its strategy of focusing on newer generations of diagnostic imaging equipment that require lighter refurbishment, according to the Rosemont, IL-based firm. The company is also expanding the scope of its technology offerings to include continuity, availability, network, and desktop management services.

The new business will operate under the name MedAssets Exchange, and will serve as an independent preferred supplier of reconditioned and interim diagnostic equipment to industry organizations, including Comdisco. Comdisco’s divested assets comprise their used medical equipment inventory, including angiography, cardiac catheterization, C-arm, CT, digital imaging, MRI, x-ray, and mobile diagnostic and imaging systems. MedAssets Exchange will be based in Wood Dale, IL, and will utilize the facility that served as Comdisco Medical Exchange’s refurbishing center.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.